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phosphorylation of PLC-γ1, the induction of NFAT, and the expression of IL-2 are impaired by Nef in sub-
optimally activated/resting T cells. Our data indicate that Nef has a dual role in the modulation of TCR
signaling aimed at favoring HIV-1 replication and spread in both quiescent and metabolically active CD4+ T
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The efﬁciency of HIV-1 replication in CD4+ T lymphocytes is
strongly dependent on the activation state of the cells.While activated
T cells are fully permissive for viral replication, quiescent T cells do not
support efﬁcient retrotranscription, integration, and expression of the
HIV-1 genome due to low levels of nucleotides, ATP, and nuclear
transcription activators (Coiras et al., 2009; Stevenson, 2003).
Therefore, it is not surprising that HIV-1 has evolved mechanisms to
stimulate the signaling pathway of the T cell receptor (TCR). Several
experimental evidences indicate that Nef, an HIV-1 protein required
for efﬁcient viral replication in vivo and AIDS disease progression
(Deacon et al., 1995; Kirchhoff et al., 1995), has a key role in the
modulation of TCR signaling. Nef is a ~27 kDa myristoylated protein
expressed soon after infection that associates with cell membranes
and down-modulates an array of cell surfacemolecules including CD4,
MHC class I and class II, CD28, and chemokine receptors, thus favoring
at different levels HIV-1 spread (Arien and Verhasselt, 2008; Kirchhoff
et al., 2008). In addition, many interactions between Nef and cellularfactors belonging to the TCR signaling pathway such as Lck, Vav, and
the TCR ζ chain have been described (reviewed by Renkema and
Saksela, 2000). Because of the correlation between HIV-1 replication
and cellular activation, a positive inﬂuence of Nef on T cell signaling
could be expected. Experimental evidence supporting such positive
effect of Nef has indeed been reported. Nef expression in the Jurkat T
cell line or in primary CD4+ T cells increased production of IL-2, a key
indicator of T cell activation, upon TCR triggering with antibodies
against TCR/CD3 and CD28 co-receptor (Schibeci et al., 2000; Schrager
and Marsh, 1999; Wang et al., 2000) or exposure to mitogens that
bypass surface receptors (Keppler et al., 2006). Nef also increased the
activity of NFAT, another hallmark of T cell activation, in stimulated
Jurkat cells transfected with Nef-expressing vectors (Fenard et al.,
2005; Manninen et al., 2000) or infected with HIV-1 (Schindler et al.,
2006). Importantly, it was reported that Nef sensitizes HIV-infected
quiescent CD4+ T lymphocytes to activation, thus favoring IL-2
production and viral replication in response to TCR stimulation (Wu
and Marsh, 2001). Finally, Nef expression itself was shown to induce
in Jurkat cells a transcriptional program that closely resembles that
induced by TCR/CD3 stimulation (Simmons et al., 2001). However,
contrasting with these results, several reports have suggested that Nef
inhibits T cell activation. This latter phenotype was observed in Nef-
expressing T cell clones that were defective for their capacity to
respond to stimulation with mitogens or anti-TCR/CD3 antibodies in
terms of activation of NF-κB and AP-1 transcription factors or IL-2
production (Bandres and Ratner, 1994; Collette et al., 1996;
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remodeling and recruitment at the plasmamembrane of Lck and other
signaling molecules that normally follow TCR engagement (Haller et
al., 2006; Haller et al., 2007; Thoulouze et al., 2006). Thoulouze et al.
(2006) also reported that Nef reduced the formation of the
immunological synapse (IS) between infected lymphocytes and
antigen-presenting cells (APC), thus leading to lower IL-2 production
by T cells, although these results were not conﬁrmed in a more recent
study (Arhel et al., 2009). It was suggested that these negative effects
of Nef may favor HIV-1 replication by preventing full activation and,
consequently, activation-induced cell death (AICD) of infected T
lymphocytes (Fackler et al., 2007).
The confusion surrounding the effects of Nef on the TCR pathway
may reﬂect differences in the cell systems employed, the types of nef
alleles used, the duration and the level of Nef protein expression. In
addition, the various conditions used to stimulate T cells, including
the nature, the relative amount, and the duration of the stimulus,
might have diversiﬁed effects on Nef function. Finally, the activity of
Nef may be inﬂuenced by other viral proteins; thus, the impact on T
cell activation may vary whether the protein is expressed by itself or
in the context of HIV-1 infection.
In the present study, we examined the impact of Nef expression in
the capacity of HIV-1-infected CD4+ T lymphocytes to respond to
TCR-mediated stimulation. Quiescent and resting CD4+ T lympho-
cytes, both representing important targets of in vivo HIV-1 infection,
have been infected with wt or Nef-defective virus, then stimulated
with antibodies that cross-link TCR/CD3 and CD28 to mimic antigen
stimulation. Results presented herein show that the HIV-1 Nef protein
modulates the TCR function either positively or negatively depending
on the activation state of the infected T cells.Fig. 1. Analysis of quiescent CD4+ T lymphocytes infected with wt or Nef-deﬁcient HIV
(250 ng×106 cells) of VSV-G-pseudotyped wt or ΔNef HIV-1 or not infected (n.i.), then cul
results obtained in one out of at least four independent experiments. (A) Whole-cell extract
CD28. The level of the latter three proteins wasmeasured by densitometry, normalized by tub
infected cells were stained with anti-Nef antibody together with anti-Lck (left panels),
immunoﬂuorescence microscopy. Nuclei were stained with DRAQ5. Depicted is a represen
expression of CD4 and CD28 was analyzed by ﬂow cytometry. The geometric mean ﬂuor
histogram shows unlabeled cells. (D and E) At 5 days p.i., n.i., wt- and ΔNef-infected cells
methods. (D) Viral replication was assessed at 16, 24, and 48 h post-activation by measuri
secreted in the supernatant of cells derived from 10 healthy donors was measured by ELISA. (
setting n.i. to a 100. *P=0.02, n.s=not statistically signiﬁcant.Results
Role of Nef in the activation of HIV-infected quiescent CD4+ T cells
To explore the capacity of the HIV-1 Nef protein to affect the
activation state of quiescent primary CD4+ T lymphocytes, freshly
puriﬁed CD4+ T cells have been infected with the NL4-3 strain of HIV-
1 either wt or Nef-deﬁcient (ΔNef). Both viruses were pseudotyped
with the vesicular stomatitis virus glycoprotein (VSV-G) to allow
entry into target cells by endocytosis and bypass the requirement of
Nef for optimal viral infectivity (Chazal et al., 2001). After 5 days of
culture in the absence of mitogenic stimuli, infected as well as
uninfected (n.i.) control cells were harvested to analyze by Western
blotting the expression of Nef and of three signaling molecules, Lck,
CD4, and CD28, that are known targets of Nef-induced degradation
(Greenway et al., 2003). Fig. 1A shows that the Nef proteinwas readily
detected in cells infected with wt virus despite no measurable viral
replication occurred (data not shown), in agreement with a previous
study showing Nef expression in HIV-infected quiescent T cells
lacking viral DNA integration (Wu and Marsh, 2001). If compared to
n.i. cells, the steady-state level of CD28 remained unvaried upon
infection, while CD4was reduced by 30–40% (Pb0.05) in cells infected
with wt but not with ΔNef virus. On the other hand, about 20%
reduced Lck levels were consistently observed in both wt- and ΔNef-
infected cells (Pb0.05). In addition, the intracellular distribution of
CD4, CD28, and Lck in wt-infected cells was analyzed by double-
staining with an anti-Nef antibody together with an anti-CD4, anti-
CD28 or anti-Lck antibody followed by immunoﬂuorescence micro-
copy. ΔNef-infected cells could not be identiﬁed due to the lack of an
HIV-1-speciﬁc marker different from Nef to be used for this analysis.-1. Freshly isolated CD4+ T lymphocytes were infected with equivalent p24 doses
tivated in the absence of mitogenic stimuli for 5 days. Panels A–D show representative
s were analyzed by Western blotting with antibodies against Nef, tubulin, Lck, CD4, and
ulin and expressed by setting at a 100% the value foundwith n.i. sample. (B) N.i. andwt-
anti-CD4 (central panels), or anti-CD28 (right panels) antibody and processed for
tative confocal section through the middle of the cell. Bar: 5 μm. (C) The cell surface
escence intensity (MFI) values of the life cell population are reported. The unshaded
have been activated with anti-CD3 and -CD28 antibody as described in Materials and
ng p24 in the culture supernatant with speciﬁc ELISA. (E) At 16 h post-activation, IL-2
F) The average IL-2 release by cells shown in panel (E) was calculated and expressed by
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anti-Nef antibody in four independent experiments. As shown in
Fig. 1B, if compared to uninfected cells, Nef+ cells maintained the
intracellular distribution of CD28 but accumulated both CD4 and Lck
in large perinuclear vesicles. Moreover, ﬂow cytometric analysis
indicated that the surface level of both CD28 and CD4 did not change
signiﬁcantly upon HIV infection with or without Nef expression
(Fig. 1C). Overall, these results indicate that during the 5-day period
that follows HIV-1 infection of quiescent T cells, Lck levels are reduced
through a Nef-independent mechanism and that the accumulated Nef
protein induces the intracellular retention/degradation of CD4
without affecting the cell surface expression of this receptor or CD28.
Then, we tested the role of Nef in the response to stimulation of HIV-
infectedquiescent T cells, speciﬁcally in theproductionof progenyvirions
and IL-2. Five days post-infection, n.i., wt- and ΔNef-infected quiescent T
cellswere activatedwith anti-CD3 and anti-CD28 cross-linked antibodies
then monitored at various time for the release of p24 and IL-2 in the
culturemedium by speciﬁc ELISA. As expected, a positive effect of Nef on
HIV-1 replication was consistently observed with a 2-fold higher p24
release at 48 h post-activation by cells infectedwithwt virus if compared
to those infected with ΔNef (Fig. 1D). Upon stimulation, all tested T cell
populations derived from healthy donors produced IL-2 with a maximal
release after 16 h, although the relative amount of cytokine varied
considerably among individuals (Fig. 1E). In 9 out of 10 donors, cells
infectedwithwtvirusproducedhigher amountsof IL-2 if compared ton.i.
cells (from 10% to 110% higher levels; Fig. 1E). Conversely, cells infected
with Nef-negative virus responded to stimulation producing IL-2
amounts that were lower if compared to wt-infected cells (from 10% to
75% lower levels) in the majority of the donors (8 out of 10). By
comparing the average IL-2 releaseof all testeddonors, thiswas increased
by 40% inwt-infected cells if compared to n.i. (P=0.02) orΔNef-infected
cells (P=0.02), while the latter two cell types did not differ (P=0.74)
(Fig. 1F). Therefore,we concluded that in this cell systemHIV-1positively
inﬂuences the production of IL-2 in a Nef-dependent manner.
Early TCR signaling events in quiescent CD4+ T cells are not altered by
HIV-1
Next, we askedwhether the positive effect of Nef in the activation of
HIV-infected quiescent T cells occurred through variations in the
phosphorylation of intracellular substrates that follows TCR stimulation.
Quiescent CD4+ T cells were infected and incubated for 5 days as
described above then stimulated with cross-linked anti-CD3 and anti-
CD28 antibodies for variable time before Western blot analysis with an
anti-phosphotyrosine (p-Tyr) antibody. Fig. 2A shows that various
phosphoproteins were induced 1 min after TCR triggering, then slowly
decreased remaining detectable till 30–60 min. Based on their apparent
molecular masses, some phosphoproteins corresponded to activated
molecules that are distinctive of TCR signaling such as p-PLC-γ1
(140 kDa), p-Vav (95 kDa), p-ZAP-70 (70 kDa), and p-Lck (56 kDa).
Thus, the total protein level of these proteins was evaluated by
reprobing the membrane with speciﬁc antibodies (Fig. 2A) and the
efﬁciency of phosphorylation was calculated by normalizing phospho-
bands for their corresponding loading controls. By comparing n.i., wt-
and ΔNef-infected cells derived from 5 donors, it was evident that the
extent and the kinetics of tyrosine phosphorylation of PLC-γ1, Vav, and
ZAP-70 (with a peak after 1 min of stimulation) did not differ
signiﬁcantly (representative results are shown in Fig. 2B). By this
analysis, the extent of Lck phosphorylation was extremely variable
between different experiments (data not shown) and thus it could not
be evaluated. This was possibly due to the high basal level of Lck
phosphorylation in this cell system and/or to the presence of other
phosphorylated proteins co-migrating with Lck.
During T cell activation, costimulation by CD28 induces the PI3K-
dependent activation of the serine/threonine kinase Akt, an event that
starts a complex signaling cascade ultimately conducting to prolifer-ation and other cellular activities (Song et al., 2008). Therefore,
infected T cells were stimulated via CD3/CD28 then monitored for Akt
activation by measuring with Western blotting both the total Akt
protein and the form phosphorylated at the regulatory Ser473 site.
Apparently, Akt activation/phosphorylation was similarly induced in
n.i., wt- and ΔNef-infected T cells (Fig 2C).
CD4-induced Lck activation is maintained in quiescent T cells infected
with wt and Nef-deﬁcient HIV-1
To investigate whether HIV-1 and, more speciﬁcally, the Nef protein
could modulate Lck activity, infected quiescent CD4+ T cells were
stimulated by CD4 cross-linking that should result in the phosphorylation
of associated Lck at the Y394 residue and thus in the full activation of the
kinase (Holdorf et al., 2002). Total extracts of cells unstimulated or
stimulated for variable time (1, 5, and 10 min)were analyzed byWestern
blotting with anti-p-Tyr antibody followed by reprobing with anti-Lck
antibody. As shown in Fig. 3A, CD4 triggering induced after 1 min the
phosphorylation of Lck that reached a maximum after 5 min, while the
total protein level decreased progressively due to the rapid consumption
of activated Lck. In wt- andΔNef-infected cells, despite the lower steady-
state protein level of Lck, the extent and the kinetic of Lck activation/
consumptionwas similar to that observed in uninfected cells. In addition,
HIV-infected T cells stimulated via CD4 were tested for the phosphory-
lation of the TCR ζ subunit, one of the early substrate for Lck's kinase
activity (vanOers, 1999). To this end, total cell lysatesofn.i.,wt- andΔNef-
infected CD4+ T lymphocytes stimulated with cross-linked anti-CD4
antibody for 5 min were immunoprecipitated with anti-p-Tyr antibody
and the recovered immunocomplexeswere analyzedbyWesternblotting
with anti-ζ chain antibody. Fig. 3B shows that the amounts of ζ chain
found in the precipitated phosphoproteins increased upon CD4 stimula-
tion and that this incrementwas similar in n.i., wt- andΔNef-infected cell
samples. These results were conﬁrmed by the reciprocal analysis of
tyrosine-phosphorylated proteins in the anti-ζ-chain immunocomplex
(data not shown) and suggest that the function of Lck is maintained in
quiescent T cells upon HIV-1 infection with and without Nef expression.
Nef superinduces NFAT during activation of HIV-infected quiescent T cells
Then, we analyzed the impact of HIV-1 infection in the late steps of
signal delivery in quiescent T cells stimulated by CD3/CD28
engagement. Speciﬁcally, we investigated the NF-κB and NFAT
proteins that are key regulators of both T cell activation (Macian,
2005; Schulze-Luehrmann and Ghosh, 2006) and HIV-1 gene
expression (Kinoshita et al., 1998; Nabel and Baltimore, 1987).
Primary CD4+ T cells were infected and stimulated as described in
Fig. 2 then harvested at various times after stimulation to prepare
total cell extracts. The expression and activation of proteins belonging
to the NF-κB pathway (IKKα/β, IκBα, NF-κB p65) was quantiﬁed by
performing a Western blotting analysis with antibodies against the
total proteins or their phosphorylated forms. As shown in Fig. 4A, after
15 min of stimulation, we observed phosphorylation of regulatory
residues in the IKKα catalytic subunit that is speciﬁc for activated IKK
complex along with phosphorylation of the IKK target protein IκBα.
As expected, IκBα phosphorylation coincided with the reduction of
total IκBα protein level and the appearance of phosphorylated/
activated NF-κB that was maximally induced after about 6 h. These
events occurred similarly in cells not infected or infected with HIV-1
either wt or Nef-defective, indicating that the capacity of quiescent
CD4+ T cells to activate the NF-κB pathway is not altered by the virus.
Finally, we analyzed the transcription factors NFATc1 and NFATc2
(also called NFAT2 and NFAT1, respectively) that reside in the
cytoplasm in a hyperphosphorylated state in quiescent T cells and
translocate into the nucleus upon calcineurin-mediated dephosphor-
ylation induced by TCR/CD28 ligation. Cell extracts were analyzed by
immunoblotting with antibodies that detected both the inactive
Fig. 2. Phosphorylation of signaling proteins upon primary activation of T cells infected with wt or Nef-deﬁcient HIV-1. Five days p.i., quiescent CD4+ T lymphocytes were stimulated
for variable time with cross-linked anti-CD3 and anti-CD28 antibodies. (A) Equal amounts of total cell lysates were analyzed by Western blotting with anti-p-Tyr antibody (top
panel). The membrane was stripped and reprobed with speciﬁc antibodies anti-PLC-γ1, anti-Vav, and anti-ZAP-70 (lower panels). (B) Phosphorylation of PLC-γ1, Vav, and ZAP-70
measured after 1 min (t1) of stimulation was calculated by densitometric analysis normalizing phospho-bands for their loading controls and setting to 1 the signal of n.i. cells before
stimulation (t0). (C) Total cell lysates were analyzed by Western blotting with an antibody recognizing the activated Ser473-phosphorylated (p) form of Akt (top). Then, the
membrane was reprobed with an antibody against total Akt (center). Phosphorylation of Akt was obtained by normalizing phospho-bands for their loading controls and setting to 1
the value obtained with n.i. cells stimulated for 1 min (bottom). Representative results of 1 out of 3 independent experiments are shown.
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forms. As shown in Fig. 4B, a large NFATc1 isoform and up to three
faster migrating proteins corresponding to active dephosphorylated
forms were induced 4 h after stimulation, then almost completely
disappeared 18 h post-stimulation. This process was more efﬁcient
(3-fold higher signals, Pb0.05) in cells infected with wt HIV-1 if
compared to n.i. or ΔNef-infected cells. As to NFATc2, a major isoform
was induced upon stimulation (Pb0.01) (Fig. 4C). Notably, in cells
infected with wt virus, NFATc2 appeared earlier (18 rather than 48 hpost-stimulation) than in n.i. and ΔNef-infected cells. These results
suggest that the Nef protein is able to superinduce NFAT transcription
factors.
Role of Nef in the activation state of HIV-infected resting CD4+ T cells
To further investigate the role of Nef in T cell activation, we
analyzed the impact of HIV-1 infection with and without Nef
expression in the capacity of pre-activated CD4+ T lymphocytes to
Fig. 3. Lck activation in quiescent HIV-infected CD4+ T cells stimulated through CD4
engagement. (A) Quiescent HIV-infected CD4+ T cells were stimulated 5 days p.i. with
cross-linked anti-CD4 antibody for the indicated time, then whole-cell extracts have
been prepared and analyzed by Western blotting using antibodies anti-p-Tyr ﬁrst, then
anti-Lck. Total Lck and normalized p-Lck levels were expressed by setting to 100% and 1,
respectively, the valuemeasured in n.i. cells before stimulation (t0). (B) Total extracts of
cells stimulated or not by CD4 ligation for 5 min have been immunoprecipitated with
anti-p-Tyr antibody then analyzed by Western blotting with anti-ζ-chain antibody. As
controls, total lysates of n.i. cells not stimulated or stimulated via CD4 (ﬁrst and second
lanes) and an immunoprecipitation reaction in the absence of cell lysate (ctr lane) were
loaded. Results obtained in a representative experiment out of three are shown.
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have been stimulated through CD3/CD28 ligation and cultivated for
6 days, till when cells stopped proliferating and dumped expression of
activation markers such as cell surface CD25 and CD69 (data not
shown). Here we will refer to these cells as resting T cells. Next,
resting cells have been infected with HIV-1, wt or Nef-defective, or
mock infected and further cultivated for 3 days to allow accumulation
of the Nef protein (Fig. 5A). If compared to quiescent T cells at 5 days
p.i., resting cells infected with wt virus for 3 days displayed from 5- to
7-fold higher amounts of Nef and expressed detectable levels of other
viral proteins as determined by Western blotting analysis (Fig. 5B).Fig. 4. Nef speciﬁcally superinduces NFATc1 and NFATc2, not NF-κB, in response to primary
5 days p.i. via CD3/CD28 for the indicated time, then whole-cell extracts have been prepared
κB pathway (IKKα/β, IκBα, NF-κB) was quantiﬁed by using antibodies against the phospho
protein (central panels), and ﬁnally normalizing phosphorylated bands for their loading con
(t0) was set to 1. (C and D) Whole-cell extracts were analyzed by immunoblotting with
phosphorylated and the active dephosphorylated NFAT forms. Arrowheads indicate protein b
actin antibody loading control. For each pathway, a representative of at least three experimConcomitantly, a small percentage of p24+ (between 1 and 6%) was
detected by ﬂow cytometry in resting but not in quiescent popula-
tions of infected cells (Fig. 5C and data not shown). Similarly to
quiescent infected CD4+ T cells, HIV-1 infection of resting CD4+ T cells
did not affect steady-state CD28 protein levels but slightly reduced
total Lck levels (by ~10%; P=0.05) in a manner that was independent
of Nef expression (Fig. 5A). As to CD4, upon infection with wt and, to a
slightly lower extent, ΔNef virus, the total protein amounts were
consistently reduced (by 10–20%; P = 0.03) and the cell surface
expressionwas strongly suppressed (10- to 40-fold) as determined by
Western blotting and FACS analysis, respectively (Fig. 5A and C). The
Nef-independent down-regulation of CD4 is consistent with the
capacity of the late Vpu and Env viral proteins to induce CD4
degradation (Geleziunas et al., 1994). Conversely, p24+ cells infected
with wt but not with ΔNef virus had reduced levels of surface CD28, in
agreement with Nef-speciﬁc down-regulation of this molecule.
Then, resting T cells infected for 3 days have been re-stimulated
via CD3/CD28 and monitored for the release of soluble p24 and IL-2 in
the culture medium. If compared to infected T cells stimulated for the
ﬁrst time, secondary activated wt- and ΔNef-infected cells produced
p24 at earlier time points but the growth disadvantage of Nef-
deﬁcient virus was always maintained in 6 tested donors (Fig. 5D
shows a representative experiment). Upon secondary stimulation, the
production of IL-2 was similar in n.i. and wt-infected cells but
increased in cells infected with ΔNef virus (Fig. 5E). This responsewas
evident in 5 donors showing 35–110% higher IL-2 levels with ΔNef,
while donor #6 instead showed amodest Nef-mediated increase of IL-
2 release. Considering the average IL-2 released by all donors, this was
increased by 55% in ΔNef-infected cells if compared to wt-infected
(P=0.02) and n.i. cells (P=0.008) (Fig. 5F). Apparently, in these
experimental settings the Nef protein had a negative impact on IL-2
release and was advantageous for viral replication independently of
its function in IL-2 regulation. By comparing the levels of IL-2
produced in the quiescent versus resting cell systems (Fig. 5G),
uninfected resting cells had a propensity to release higher amounts of
cytokine (3-fold induction if compared to quiescent T cells, P=0.13),
in agreement with their higher metabolic status. This induction was
somewhat lower (2-fold, P=0.16) or, conversely, signiﬁcantly higher
(5-fold, P=0.04) upon infection with wt or ΔNef virus, respectively.
These results indicate that IL-2 expression in resting cells is inhibited
by Nef rather than stimulated as in quiescent cells.Nef alters early TCR signaling and NFAT induction in HIV-infected resting
T cells
At last, resting T cells, n.i. or infected with wt or ΔNef virus, have
been re-stimulated via CD3/CD28 and collected at various time points
to investigate the pattern of tyrosine-phosphorylated proteins. T cells
responded to secondary stimulation very rapidly, within 30 s, by
upmodulating a series of phosphoproteins that, based on their
molecular masses, corresponded to the TCR signaling cascade
described earlier (Fig. 6A). The efﬁciency of PLC-γ1 phosphorylation
could be easily quantiﬁed since p-PLC-γ1 was almost undetectable
before T cells re-stimulation. By three independent analyses,
following TCR stimulation an average 2.5-fold phosphorylation of
PLC-γ1 was reached in n.i. cells as well as in cells infected with
wt or ΔNef virus (Pb0.05). This pick, however, was consistently
observed after 1 min in cells infected with wt virus rather than afteractivation of HIV-infected T cells. Quiescent HIV-infected CD4+ T cells were stimulated
and analyzed byWestern blotting. (B) Phosphorylation of proteins belonging to the NF-
rylated form (top panels), reprobing the membrane with antibodies against the total
trols (bottom). The basal phosphorylation level measured in n.i. cells before stimulation
antibodies speciﬁc for NFATc1 and NFATc2 antibodies that detect both the inactive
ands up-regulated upon T cell stimulation. Themembranes were reprobedwith an anti-
ents is shown.
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Fig. 5. Analysis of resting CD4+ T cells infected with wt or Nef-deﬁcient HIV-1. Freshly isolated CD4+ T lymphocytes were stimulated via CD3/CD28, cultivated for 6 days till when
they stopped growing and reacquired a resting phenotype, infected with VSV-G-pseudotyped wt and ΔNef HIV-1 or not infected, then cultivated for 3 more days. (A) At 3 days p.i.,
whole-cell extracts were prepared and analyzed by Western blotting with antibodies against Nef, tubulin, Lck, CD4, and CD28 as described in Fig. 1. (B) Lysates of resting T cells
3 days p.i. and quiescent T cells 5 days p.i., both infected with wt virus, were analyzed Western blotting with an anti-HIV human serum, anti- Nef, and anti-actin antibody. Based on
their apparent molecular masses, some viral proteins reacting with the anti-HIV-1 serum are indicated. The levels of Nef were normalized by actin and expressed by setting quiescent
cell sample at a 100%. (C) Expression of cell surface CD4 or CD28 and intracellular p24 was analyzed by two-color ﬂow cytometry at 3 days p.i. The MFI value speciﬁc for CD4 and
CD28 of n.i. cells and of gated p24+ infected cells is indicated. (D) Resting cells were re-stimulated 3 days p.i. by CD3/CD28 ligation and viral replication was assessed 18 and 48 h
later by measuring p24 in the culture supernatant with speciﬁc ELISA. Results shown in panels A–D are representative of six independent experiments. (E and F) At 16 h post-
activation, IL-2 secreted in the supernatant of cells derived from 6 healthy donors was measured by ELISA. The values obtained for each donor (E) and the average release of IL-2 (F)
are shown. (G) A comparative analysis of IL-2 release between resting cells in panel E (n=6) and quiescent cells shown in Fig. 1E (n=10) was performed. *Pb0.05, **Pb0.001.
322 F. Neri et al. / Virology 410 (2011) 316–32630 s as in n.i. and ΔNef-infected cells (Fig. 6A shows a representative
experiment).
To test whether the delayed kinetics of PLC-γ1 phosphorylation in
wt-infected cells also resulted in altered downstream signaling
events, the activation of NFAT was analyzed as described earlier. As
to NFATc1, its active isoforms were already abundantly expressed
before TCR re-stimulation and no differences were observed between
n.i., wt- orΔNef-infected cells at the time points analyzed (Fig. 6B). On
the other hand, a large active NFATc2 isoform transiently appearing
18 h post-activation accumulated to about 3-fold higher extents in
ΔNef-infected cells compared to wt-infected and n.i. cells (Pb0.01).
Overall, these results support a negative role of Nef in the response to
secondary activation by HIV-infected resting T cells.
Discussion
Previous studies, despite controversial, have highlighted the
importance of the HIV pathogenicity factor Nef in the modulation of
T cell activation. Here we have investigated the role of Nef in the TCR-
mediated activation of primary CD4+ T lymphocytes undergoing HIV-
1 infection. We employed for this study either freshly isolated
quiescent CD4+ T cells or in vitro pre-activated CD4+ T cells that
returned to an arrested state after few days in culture. These two cell
populations consist in CD4+ T lymphocytes with a naïve or memory
phenotype and in resting/sub-optimally activated CD4+ T lympho-
cytes, respectively; thus, they recapitulate the features of the in vivo T
cell targets of HIV-1 infection (Coiras et al., 2009). We found that,
upon TCR-mediated stimulation of HIV-infected quiescent CD4+ T
cells, the activation of NFATc1 and NFATc2 transcription factors was
enhanced in a Nef-dependent manner. This result is in line with thecapacity of Nef to enhance NFAT-dependent transcription of reporter
genes shown in Jurkat cells (Fenard et al., 2005;Manninen et al., 2000;
Schindler et al., 2006). We found that NFAT super-activation
correlated with higher release of IL-2 and enhanced viral replication
induced by Nef, conﬁrming and extending previously reported data
(Wu and Marsh, 2001). Indeed, numerous experimental ﬁndings
showed that, in activated T cells, induction of both the IL-2 promoter
and the HIV-1 long terminal repeat (LTR) depend critically on the
activity of NFAT (Chow et al., 1999; Cron et al., 2000; Fortin et al.,
2001; Kinoshita et al., 1998). Of note, increased production of IL-2 can
boost HIV-1 replication through autocrine mechanisms, for instance,
by further stimulating NFAT (Barlic et al., 2004) and, in addition, can
promote viral spread in bystander CD4+ T cells through their
recruitment and activation. In HIV-infected quiescent T cells, the
phosphorylation/activation of proximal TCR/CD3 and CD28 effectors
(i.e., PLC-γ1, Vav, ZAP-70, Akt) occurred normally as in uninfected
cells, suggesting that to induce NFAT activation Nef uses mechanisms
that are downstream in the pathway. This observation is in line with a
study performed in Jurkat cells showing that Nef activates the
calcium/calcineurin pathway independently of the TCR and syner-
gizes with the Ras pathway in potently inducing NFAT-dependent
transcription (Manninen et al., 2000). However, the detailed
mechanism that connects Nef to calcium metabolism and NFAT
activation remains to be elucidated. A previous report showed that the
serine/threonine kinase Pak1 is implicated in NFAT activation in T
cells (Yablonski et al., 1998). Since Nef associates with activated Pak2
(Renkema and Saksela, 2000), another member of the Pak family of
closely related kinases, it would be interesting to investigate the role
of the Nef/Pak2 complex in the regulation of NFAT activity.
Surprisingly, upon activation of primary quiescent CD4+ T cells, we
Fig. 6. PLC-γ1 phosphorylation and NFAT activation upon secondary stimulation of T cells infected with wt or Nef-deﬁcient HIV-1. Resting CD4+ T lymphocytes infected with wt or
ΔNef viruses as described in Fig. 5 have been re-stimulated 3 days p.i. via CD3/CD28 for the indicated times. (A) Equal amounts of total cell lysates were analyzed byWestern blotting
with anti-p-Tyr antibody (top), followed by reprobing with anti-PLC-γ1 antibody (center). The phosphorylation of PLC-γ1 was calculated by normalizing phospho-bands for their
loading controls and setting to 1 the signal of n.i. cells at t0 (bottom). (B and C) The cells were analyzed for the activation of NFATc1 and NFATc2 as described in Fig. 4C and D. One
representative out of three independent experiments is shown.
323F. Neri et al. / Virology 410 (2011) 316–326found that HIV-1 did not alter the NF-κB pathway. Nevertheless, Nef-
induced activation of NFAT may also result in higher NF-κB activity
due to the capacity of NFAT to bind the κB regulatory elements in the
LTR and to synergize with NF-κB and the viral Tat protein in the
enhancement of HIV-1 transcription (Kinoshita et al., 1997).The analysis of the response to secondary CD3/CD28 activation of
resting HIV-infected CD4+ T cells gave different results. In this cell
system we showed for the ﬁrst time that Nef expression resulted in
delayed activation of the early signaling molecule PLC-γ1 and
impaired super-induction of NFATc2, in agreement with the capacity
324 F. Neri et al. / Virology 410 (2011) 316–326of Nef to reduce the recruitment of the TCR-proximal signaling
machinery previously reported in two studies (Haller et al., 2006;
Thoulouze et al., 2006). In those previous reports, either Jurkat cells or
pre-activated primary CD4+ T lymphocytes have been infected with
wt or ΔNef HIV-1, then stimulated by engagement with APC or
immobilized anti-CD3/CD28 antibodies. In the paper by Thoulouze et
al. (2006) the production of IL-2 by Jurkat cells was higher in ΔNef-
infected cells if compared to cells infected with wt virus or not
infected, suggesting that the inhibitory function of Nef in this cell
system suppressed the positive effect on IL-2 expression of other viral
proteins (e. g. Tat). Similarly, we found that the average IL-2 release by
resting T cells was higher if cells were infected with ΔNef virus.
Nevertheless, with cells derived from 1 out of 6 donors we observed
the opposite phenomenon of a slightly positive effect of Nef on IL-2
production, in agreement with another study performed with resting
infected lymphocytes co-cultured with APC (Arhel et al., 2009).
Discrepancies may arise from subtle differences in the metabolic state
of the cells possibly due to minor variations in the experimental
procedures employed or even to donor-dependent features that have
not been identiﬁed, as yet. We envision that Nef can exert its negative
function on IL-2 expression only when the extent of cellular activation
has gone beyond a speciﬁc threshold. Importantly, we found that the
capacity of Nef to enhance viral replication in resting T cells was
independent of the protein's function in IL-2 production. Likely, the
relative amount of IL-2 produced upon secondary stimulation of
resting T cells largely exceeds that required for efﬁcient HIV-1 gene
expression and may not represent the best parameter to evaluate the
function of Nef in this cell system.
Overall, results obtained in this study indicate that Nef acts as a
positive or negative modulator of the TCR pathway depending on the
quiescent or active state, respectively, of the infected T cell. Possibly,
the levels and/or the availability of Nef and other viral or cellular
factors that are inﬂuenced by the cell metabolism determine the
impact of Nef in the response of infected T cells to activation. Taking
advantage of improved assays for HIV-1 integration and reverse
transcription (Agosto et al., 2007; Swiggard et al., 2005; Vatakis et al.,
2007), it would be interesting to compare the levels of integrated viral
DNA and accumulated viral transcripts in quiescent and resting T cells
prior as well as after TCR stimulation. While these aspects warrant
further investigation, results obtained herein suggest that the
inhibitory effect of Nef may result, at least in part, from the protein's
capacity to down-regulate surface CD4 and CD28 co-receptors, a
phenomenon that we observed in resting but not in quiescent CD4+ T
cells infected with HIV-1. It is expected that reduced cell surface
expression of CD4 will not allow efﬁcient recruitment of Lck at the
activated TCR (Holdorf et al., 2002). Analogously, cells with low
surface CD28 levels should be impaired in the response to stimulation
with anti-C28 antibody, form aberrant IS with APC, and respond to
both stimuli with reduced activation of PLC-γ1 (Michel et al., 2001)
and Lck (Holdorf et al., 2002). These negative effects will not occur in
HIV-infected quiescent CD4+ T cells in which CD4 and CD28 are not
down-regulated by Nef, as shown here for the ﬁrst time. It is possible
that the CD4 and CD28 down-regulation activities of Nef require
higher levels of protein expression (shown in Fig. 5B) and/or some
cellular events linked to T cell activation. At least for CD4, the latter
hypothesis is more likely, since the previously described capacity of
Nef to induce intracellular retention and degradation of neo-
synthesized CD4 molecules (Rose et al., 2005) was readily detected
in quiescent CD4+ T cells 5 days post-infection with HIV-1. In these
cells, the intracellular accumulation and reduced total protein
expression were also observed for Lck. Surprisingly, the decrease in
total Lck protein levels was found also in quiescent cells infected with
ΔNef virus as well as in wt- and ΔNef-infected resting T cells. These
results indicate that, during HIV-1 infection of both quiescent and
resting T cells, Lck levels are reduced by some viral factor(s) different
from Nef that warrants to be characterized in future studies.Moreover, we found that, despite reduced Lck expression, wt- and
ΔNef-infected quiescent T cells sustained normal Lck activation as
measured by CD4 triggeringwith speciﬁc antibody. Therefore, the role
of Nef in T cell activation cannot be ascribed to the protein's capacity
to modulate the function of Lck. Since most activities of Nef that can
have an impact on the TCR signaling pathway (CD4 and CD28 down-
regulation activities; Lck re-localization; association with activated
Pak2 kinase) are genetically separable, mutated Nef proteins with
single functional defects might provide a means to investigate the role
of each activity in the responsiveness of HIV-infected cells to
stimulation.
The seemingly contradictory effects of Nef on TCR signaling may
reﬂect a dual strategy evolved by HIV-1 to endorse its propagation in T
cells. In quiescent CD4+ T cells that are permissive for HIV-1 gene
expression but resistant to productive replication, by increasing the
cellular response to TCR activation, HIV-1 can favor rapid and efﬁcient
synthesis of viral particles. This phenomenon may have important
consequences for in vivo viral burden since quiescent CD4+ T
lymphocytes carrying HIV-1 proviral DNA contribute signiﬁcantly to
the long-lived viral reservoirs in infected patients (Ostrowski et al.,
1999; Zhang et al., 1999). On the other hand, by attenuating the ability
of sub-optimally activated T cells to respond to external TCR
triggering, HIV-1 may protect productively infected cells from AICD,
hence favoring viral replication. In support of this model, several
studies with ex vivo or in vitro HIV-infected T cells indicate that
exposure to cytokines can trigger viral replication even in the absence
of TCR engagement and full T cell activation (reviewed by Coiras et al.,
2009). Interestingly, other lymphotropic viruses such as the human T-
lymphotropic virus type 1 (HTLV-1) and herpesvirus saimiri (HSV)
use this dual strategy to modulate TCR signaling to successfully
replicate and spread in the host T cells (Jerome, 2008). In particular, a
striking similarity exists between Nef and the HTLV-1 p12I protein
that is able to increase intracellular calcium and NFAT activation
bypassing proximal TCR effectors (Ding et al., 2002) as well as to
inhibit phosphorylation of PLC-γ1, Vav, and LAT after TCR ligation
(Fukumoto et al., 2007). Recent work provided evidence that the
positive and negative effects of p12I are mediated, respectively, by the
full-length protein residing in the endoplasmic reticulum and by a
smaller proteolytically cleaved isoform located at the Golgi compart-
ment and plasma membrane (Fukumoto et al., 2009). Further studies
will be required to establish whether the previously described
secondary modiﬁcations (proteolytic cleavage, phosphorylation, and
myristoylation) and/or the localization at speciﬁc sub-cellular
compartments determine the phenotype of Nef in the regulation of
TCR signaling. The molecular dissection of Nef's activity in the
function of the TCR will enhance our understanding of how this
viral protein increases HIV-1 replication and may help the develop-
ment of novel strategies for the treatment of AIDS.Materials and methods
Cells and viruses
293T cells and primary human CD4+ T lymphocytes puriﬁed as
described previously (Cerboni et al., 2007) were maintained in
Dulbecco's modiﬁed Eagle's medium and RPMI 1640 medium,
respectively, both supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 units/ml penicillin–streptomycin (all from
GIBCO-BRL). Stocks of infectious VSV-G-pseudotyped NL4-3 virus,
either wild type (NIH Reagent Program) or unable to express Nef due
to two stop mutations (ΔNef) (Chowers et al., 1994), were prepared
by transfecting with the standard calcium-phosphate method 20 μg of
proviral plasmid and 3.5 μg of pCMV-VSV-G into 293T cells and
collecting cell culture supernatant after 48 h. Viral stockswere titrated
by anti-p24 enzyme-linked immunosorbent assay (ELISA) according
325F. Neri et al. / Virology 410 (2011) 316–326to manufacturer's instructions (Immunogenetics). For each experi-
ment, at least three different stocks of viruses were used.
T cell infection and activation
Primary CD4+ T cells, either freshly isolated (quiescent) or
activated 6 days earlier as described below (resting), were infected
by incubation for 4 h at 37 °C with 250 ng of p24×106 cells of VSV-G-
pseudotyped wt or ΔNef virus. Then, cells were washed twice and
cultivated at 5×106/ml in complete RPMI medium. The medium was
supplemented with 100 IU of human recombinant interleukin-2 (IL-
2)/ml in the case of resting T cells. T cell activation was performed
either immediately after cell puriﬁcation or 5 days post-infection (p.i.)
by incubating CD4+ T cells on ice for 30 min with phosphate-buffered
saline (PBS) alone or supplemented with anti-CD3 (HIT3a) and anti-
CD28 (CD28.2) or with anti-CD4 (RP4-T4) NA/LE monoclonal
antibodies (mAb) from BD Biosciences each at 10 μg/ml. Next, cells
were washed twice with cold PBS, resuspended with 20 μg/ml of anti-
mouse goat IgG (GAM; Sigma) and incubated for variable time at 37 °C
or not (t0). Finally, cells were centrifuged, washed twice with PBS and
either replaced in culture or lysed for Western blot analysis. To
analyze HIV-1 replication and IL-2 production, infected CD4+ T cells
were activated via CD3/CD28 as described, resuspended at 5×106/ml
in complete medium then an aliquot of cell culture supernatant was
collected after 16–18, 24, and 48 h for quantiﬁcation by ELISA of p24
and IL-2 (Endogen) and replaced with fresh medium.
Western blot and immunoprecipitation analysis
CD4+ T lymphocytes were washed twice with PBS and lysed in JS
buffer (50 mM Tris–HCl [pH 8.0], 1% NP-40 [vol/vol], 1.5 mM MgCl2,
150 mM NaCl, 5 mM EGTA, 10% glycerol [vol/vol], 0.2 mM phenyl-
methylsulfonyl ﬂuoride, 1 μg/ml of pepstatin, 5 μg/ml of aprotinin,
1 μg/ml of leupeptin, and 1×phosphatase inhibitor cocktail 2 (all
Sigma's reagents)) for 20 min on ice. After centrifugation, equal
amounts of clariﬁed whole-cell lysate (20–30 μg) were resolved on
10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto nitrocellulose membrane (Schleicher &
Schuell). Where indicated, total cell lysates were immunoprecipitated
with a standard procedure using mAb PY99 anti-p-Tyr (0.2 μg for
80 μg of total cell lysate) from Santa Cruz Biotechnology and Gamma
Bind Sepharose (Amersham Pharmacia Biotech) prior SDS-PAGE.
Immunoblot analysis was performed by standard methods using
0.05–0.1% Tween-20 (vol/vol) and either non fat dry milk (5%) or
bovine serum albumin (5%) as blocking reagent. The following
antibodies were used: anti-HIV-1 human serum (kind gift of Dr. M.
Federico, ISS, Rome, Italy; used at 1:500 dilution), polyclonal rabbit
serum anti-CD4 (H370; 1:200), anti-Lck (3A5; 1:200), anti-PLCγ1
(1:200), and mAb anti-p-Tyr (PY99; 1:1000) and anti-CD3-ζ (6B10.2;
1:200) from Santa Cruz Biotechnology; polyclonal rabbit serum anti-
Vav (1:500) and anti-ZAP-70 (1:1000) from Upstate Biotechnology;
mAb anti-β-actin (AC15; 1:10000) and anti-α-tubulin (DH1A;
1:10000) from Sigma; anti-Nef polyclonal sheep serum (ARP444;
1:400); anti-CD28 mAb (CD28.2; 1:500) from BD Biosciences; rabbit
antibodies anti-Akt (C67E7; 1:1000), anti-p-Akt (D9E; 1:2000), anti-
NF-κB p65 (C22B4; 1:1000), anti-p-NF-κB p65 (93H1; 1:1000), anti-
p-IκBα (14D4; 1:1000), anti-IKKα (1:1000), anti-p-IKKα/β (16A6;
1:1000), anti-NFATc1 (H-110; 1:200), anti-NFATc2 (M-300; 1:200),
and mouse mAb anti-IκBα (L35A5; 1:1000) from Cell Signaling. As
secondary antibodies, Protein G (Bio-Rad), anti-mouse, anti-rabbit or
anti-goat IgG (Amersham Pharmacia Biotech) conjugated to horse-
radish peroxidase (HRP) were used. When indicated, the membrane
was stripped with 2% SDS (w/w), 62.5 mM Tris–HCl (pH 6.7), 100 mM
β-mercaptoethanol for 20 min at 50 °C, then washed three times and
reprobed. The proteins were detected with the ECL and ECL advancesystems (Amersham Pharmacia Biotech) and proteins’ speciﬁc signals
were quantiﬁed by densitometry.
Confocal microscopy
CD4+ T lymphocytes were let adhere on polilysine-treated glass
coverslips and ﬁxed with 4% paraformaldehyde in PBS for 30 min at
RT. Immunoﬂuorescence staining was performed at RT in the
presence of 0.05% saponin and 0.5% bovine serum albumin (Sigma)
as permeabilizing and blocking agent, respectively. Cells were
incubated for 1 h with anti-Nef mAb MATG020 (1:10000) together
with rabbit antibody anti-CD4 (H370, Santa Cruz Biotechnology;
1:10) or anti-Lck (73A5, Upstate Biotechnology; 1:100). As controls,
antibodies were replaced with puriﬁed mouse IgG or rabbit serum.
After washing, cells were reacted for 1 h with Alexa488-conjugated
GAM (Molecular Probes; 1:100) and Texas Red-conjugated goat anti-
rabbit antibody (Jackson Immunoresearch; 1:100). To simultaneously
analyze Nef and CD28, cells were ﬁrst incubated for 1 h with FITC-
conjugated anti-CD28 mAb (BD Biosciences; 1:5), then reacted with
normal mouse serum (20 min at RT), with anti-Nef mAb, and, ﬁnally,
with Alexa555-conjugated GAM (Molecular Probes; 1:100). Nuclei
were permeabilized with 0.15% Triton X-100 for 5 min and stained
with DRAQ5 (Molecular Probes; 1:5000) for 10 min. Finally, cover-
slips were mounted on glass slides and confocal imaging was
performed on Olympus Fluoview FV1000 confocal IX81 inverted
microscope equipped with FV10-ASW version 1.6 software.
Flow cytometry
For simultaneous detection of surface CD4 or CD28 and intracel-
lular p24, HIV-infected or uninfected T cells were incubated with
phycoerythrin (PE)-conjugated anti-CD4 or anti-CD28 mAb (BD
Biosciences). Next, cells were ﬁxed and permeabilized with reagents
from BD Biosciences and incubated with the ﬂuorescein (FITC)-
coupled anti-p24 mAb (KC57-RD1; Beckman Coulter). Finally, cells
were ﬁxed with 1% paraformaldehyde and analyzed by two-color ﬂow
cytometry on a FACSCalibur with CellQuest software (BD Biosciences).
Statistical analyses
All experiments were performed at least three times and a
representative experiment is presented. The amounts of IL-2 are
expressed as the mean±SD. Statistical calculation of the mean
differences was performed with the Student's t-test or, for compar-
isons shown in Fig. 5G, with the non-parametric Mann–Whitney/
Wilcoxon two-sample test. A value of Pb0.05 was considered
statistically signiﬁcant.
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